Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common shares, no par value
-
Shares outstanding
-
42,837,925
-
Total 13F shares
-
27,148,766
-
Share change
-
+889,562
-
Total reported value
-
$931,197,865
-
Price per share
-
$34.30
-
Number of holders
-
61
-
Value change
-
+$31,433,436
-
Number of buys
-
37
-
Number of sells
-
16
Institutional Holders of Repare Therapeutics Inc. - Common shares, no par value (RPTX) as of Q4 2020
As of 31 Dec 2020,
Repare Therapeutics Inc. - Common shares, no par value (RPTX) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,148,766 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, MPM ASSET MANAGEMENT LLC, BVF INC/IL, FMR LLC, Redmile Group, LLC, CHI Advisors LLC, MPM ONCOLOGY IMPACT MANAGEMENT, L.P., MPM Oncology Impact Management LP, Logos Global Management LP, and ARK Investment Management LLC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.